US Patent 7332486 Phosphodiesterase 4 inhibitors
Patent 7332486 was granted and assigned to Memory Pharmaceuticals on February, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+79 characters)
Article
Patent abstract
PDE4 inhibition is achieved by novel compounds of the Formula I:
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07332486 Phosphodiesterase 4 inhibitors US Patent 7332486 Phosphodiesterase 4 inhibitors
Infobox
Patent Number
0733248600
Patent Number
733248600
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073324860
Date of Patent
February 19, 2008
0Patent Application Number
106369790
Date Filed
August 8, 2003
0Official Website
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073324860
Date of Patent
February 19, 2008
0Patent Application Number
106369790
Date Filed
August 8, 2003
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07332486 Phosphodiesterase 4 inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07332486
Date of patent
February 19, 2008
Patent application number
10636979
Date Filed
August 8, 2003
Patent primary examiner
Find more entities like US Patent 7332486 Phosphodiesterase 4 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.